Evotec Subsidiary Receives Gates Foundation Grant for Global Biotherapeutics Access
Evotec's Just-Evotec Biologics received a Gates Foundation grant on January 8 to improve monoclonal antibody development for low-income countries, following reports of benefits from Amgen's Dark Blue acquisition.